Related Experiment Video

Updated: May 4, 2026

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging
09:37

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging

Published on: July 14, 2016

7.7K

The T309G MDM2 gene polymorphism is a novel risk factor for proliferative vitreoretinopathy

Salvador Pastor-Idoate1, Irene Rodríguez-Hernández2, Jimena Rojas3

  • 1Instituto de Oftalmobiología (IOBA-Retina Group), University of Valladolid, Valladolid, Spain ; Unidad de Medicina Molecular, Departamento de Medicina, University of Salamanca, Salamanca, Spain.

Plos One
|December 19, 2013
PubMed

Insights

The T309G MDM2 polymorphism (rs2279744) G allele is linked to increased risk of proliferative vitreoretinopathy (PVR) after retinal detachment (RD) surgery. This genetic factor may play a role in PVR development and surgical outcomes.

Area of Science:

  • Genetics
  • Ophthalmology
  • Molecular Biology

Background:

  • Proliferative vitreoretinopathy (PVR) is a primary cause of retinal detachment (RD) surgery failure.
  • The p53 pathway's down-regulation is implicated in PVR pathogenesis.
  • Investigating genetic factors like MDM2 polymorphism is crucial for understanding PVR.

Purpose of the Study:

  • To evaluate the impact of the T309G MDM2 polymorphism (rs2279744) on PVR development.
  • To analyze the distribution of MDM2 genotypes in European subjects undergoing RD surgery.
  • To examine potential genetic interactions between MDM2 (rs2279744) and p53 (rs1042522) genes.

Main Methods:

  • Genotyping analysis of the T309G MDM2 polymorphism (rs2279744) in European patients with RD.
  • Comparison of genotype frequencies between PVR cases and controls.
  • Statistical analysis of genotype distribution across different European countries and assessment of odds ratios (OR) for G allele carriers.

Main Results:

  • Significant differences in MDM2 genotype frequencies were observed between PVR cases and controls.
  • The GG genotype was significantly more prevalent in cases (21.6%) compared to controls (7.3%).
  • The G allele of rs2279744 was associated with a significantly higher risk of PVR (global OR=5.9; Spain/Portugal OR=5.4; UK/Netherlands OR=7.3).

Conclusions:

  • The G allele of the T309G MDM2 polymorphism (rs2279744) is associated with an increased risk of developing PVR in patients undergoing RD surgery.
  • Geographical variations in genotype distribution suggest potential population-specific genetic influences.
  • Further research is warranted to elucidate the precise role of this single nucleotide polymorphism (SNP) in PVR pathogenesis.

More Related Videos

Limbal Approach-Subretinal Injection of Viral Vectors for Gene Therapy in Mice Retinal Pigment Epithelium06:48

Limbal Approach-Subretinal Injection of Viral Vectors for Gene Therapy in Mice Retinal Pigment Epithelium

Published on: August 7, 2015

20.8K
Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer06:21

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer

Published on: May 10, 2024

1.6K

Related Concept Videos

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
81
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
159
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
55
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
3.7K
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
121